市场调查报告书
商品编码
1466270
药品物流市场:依运输方式、产品、运输、药品供应阶段 - 2024-2030 年全球预测Pharmaceutical Logistics Market by Mode of Transportation (Air Shipping, Rail Shipping, Road Shipping), Product (Biologic & Biosimilar, Branded Drugs, Generic Drugs), Transport, Drug Supply Stage - Global Forecast 2024-2030 |
※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。
预计2023年医药物流市场规模为696.8亿美元,预计2024年将达731.2亿美元,2030年将达999.4亿美元,复合年增长率为5.28%。
药品物流是对药品、药物和医疗产品从製造商到分销商并最终到达患者的经销商的管理。它涉及一系列协调的活动,如采购、装卸、仓储、分销和运输,同时确保产品的完整性、安全性和符合监管标准。我们的目标是按时、有效率、安全地将适当条件、适量的产品运抵目的地。同时,药品温控物流需求的不断增长以及全球对疫苗和药品需求的不断增长正在推动药品物流的成长。然而,与药品物流相关的复杂流程和严格的政府法规为全球营运的公司带来了重大挑战。该公司继续专注于开发更先进的低温运输解决方案、即时监控系统、无人机送货到难以到达的地区以及永续包装解决方案,以在全球格局中保持敏捷。此外,区块链整合的进步可实现更好的可追溯性,使用人工智慧和资料分析进行预测性物流,以及确保温度敏感产品有效性的温控物流对于主要企业来说都是一个重要的机会。
主要市场统计 | |
---|---|
基准年[2023] | 696.8亿美元 |
预测年份 [2024] | 731.2亿美元 |
预测年份 [2030] | 999.4亿美元 |
复合年增长率(%) | 5.28% |
运输:更好的安全控制和可靠性将增加对空运和海运的偏好
医药物流精心策划医疗产品安全、高效、合规的运输。航空运输对于时间敏感和高价值的药品至关重要,并且由于其快速的运输时间而经常被采用。航空运输的优点是能够在世界各地运输物品并且延误较少,但也正因为如此,它往往是一种重要的运输方式。铁路运输是一种经济有效的陆上大众运输解决方案,具有可靠的时间表和由于排放低于道路运输而带来的环境效益。另一方面,道路运输反映了门到门交付的高度弹性。道路运输对于机场和港口的运输至关重要,是物流链的关键组成部分。海上运输对于国际贸易至关重要,可实现低成本、大量的运输。海上运输是国际贸易的基石,可以以低成本运输大量货物。
药品供应阶段:利用内部和外包管理进行库存管理,以满足大小企业的需求。
自我管理使公司能够直接控制其供应链,促进高品质和始终符合监管标准,并快速回应不断变化的市场需求。透过选择内部运营,公司可以更好地控制其供应链,确保满足严格的监管和品质标准,并快速回应客户需求。另一方面,外包给专业的物流提供者可以降低成本并提供专业的基础设施、广泛的网路和最尖端科技,简化供应链并向市场交付关键药物,您可以期待它更快。内部或外包物流的决定通常取决于公司的规模、资源的可用性以及药品组合的复杂性,每种途径都有自己的策略优势。
区域洞察
在美洲,美国和加拿大因其庞大的消费市场、先进的医疗基础设施以及全球製药公司的强大影响力而成为重要的医药物流中心。对个人化医疗的需求不断增长以及慢性病的高盛行率正在推动该地区对医药物流解决方案的需求。此外,由于监管情况的差异和基础设施发展的需要,拉丁美洲新兴市场的医学物流多种多样。同样,欧盟 (EU) 的药品物流领域也受到严格的监管,特别是在药品安全和可追溯性方面。该地区需要在数位技术高度普及的推动下采用综合物流解决方案来管理跨境药品流动。同时,中东物流市场透过战略地理位置和对空港、海港等基础设施的投资而不断成长。对高品质慢性病照护的需求不断增长以及私人医疗机构的激增,需要快速而复杂的物流解决方案。此外,由于医疗产业的扩张、药品製造的进步以及对医疗产品高效配送的需求不断增长,亚太地区的药品物流市场正在显着成长。患者数量的增加、政府改善医疗基础设施的努力以及製药业对新兴市场的日益关注是这一增长的关键驱动力。
FPNV定位矩阵
FPNV定位矩阵对于评估医学物流市场至关重要。我们检视与业务策略和产品满意度相关的关键指标,以对供应商进行全面评估。这种深入的分析使用户能够根据自己的要求做出明智的决策。根据评估,供应商被分为四个成功程度不同的像限。最前线 (F)、探路者 (P)、利基 (N) 和重要 (V)。
市场占有率分析
市场占有率分析是一种综合工具,可以对药品物流市场供应商的现状进行深入而详细的研究。全面比较和分析供应商在整体收益、基本客群和其他关键指标方面的贡献,以便更好地了解公司的绩效及其在争夺市场占有率时面临的挑战。此外,该分析还提供了对该细分市场竞争特征的宝贵见解,包括在研究基准年观察到的累积、分散主导地位和合併特征等因素。详细程度的提高使供应商能够做出更明智的决策并制定有效的策略,以获得市场竞争优势。
1. 市场渗透率:提供有关主要企业所服务的市场的全面资讯。
2. 市场开拓:我们深入研究利润丰厚的新兴市场,并分析其在成熟细分市场的渗透率。
3. 市场多元化:包括新产品发布、开拓地区、最新发展和投资的详细资讯。
4. 竞争评估和情报:对主要企业的市场占有率、策略、产品、认证、监管状况、专利状况和製造能力进行全面评估。
5. 产品开发与创新:包括对未来技术、研发活动以及突破性产品开发的见解。
1. 医药物流市场的市场规模与预测是多少?
2.医药物流市场预测期内我们应该考虑投资哪些产品与应用?
3. 医药物流市场的技术趋势和法规结构是什么?
4.医药物流市场主要供应商的市场占有率为何?
5.进入医药物流市场的合适型态和策略手段是什么?
[191 Pages Report] The Pharmaceutical Logistics Market size was estimated at USD 69.68 billion in 2023 and expected to reach USD 73.12 billion in 2024, at a CAGR 5.28% to reach USD 99.94 billion by 2030.
Pharmaceutical logistics is managing the flow of medicines, drugs, and healthcare products from manufacturers to distributors and ultimately to patients. It involves a series of coordinated activities, including procurement, handling, warehousing, distribution, and transportation, while ensuring the products' integrity, safety, and compliance with regulatory standards. The aim is to deliver the right products in the appropriate condition and quantity to the desired location on time, efficiently, and securely. Meanwhile, the growing need for temperature-controlled logistics for medicine and increased demand for vaccines and drugs worldwide has bolstered the growth of pharmaceutical logistics. However, the concerns associated with the complex process and the stringent government regulations related to pharmaceutical logistics present a significant challenge for companies operating in the global space. Companies are constantly focusing on developing more advanced cold chain solutions, real-time monitoring systems, drone delivery for inaccessible regions, and sustainable packaging solutions to remain agile within the global landscape. Moreover, the integration of blockchain for better traceability, the use of AI and data analytics for predictive logistics, and advancements in temperature-controlled logistics to ensure the efficacy of temperature-sensitive products are advent and present a significant opportunity for the key companies.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 69.68 billion |
Estimated Year [2024] | USD 73.12 billion |
Forecast Year [2030] | USD 99.94 billion |
CAGR (%) | 5.28% |
Mode of Transportation: Growing preference for air and sea shipping due to their better safety controls and reliability
Pharmaceutical logistics involves meticulous planning for the safe, efficient, and compliant transport of medical products. Air shipping is often employed for its rapid transit times, crucial for time-sensitive or high-value pharmaceuticals. It affords the advantage of global reach with minimal delays, though it tends to be the significant mode of transport. Rail shipping is a cost-effective solution for bulk shipments over land, providing reliable schedules and environmental benefits due to lower emissions than road transport. On the other hand, road shipping offers high flexibility for door-to-door deliveries. It is vital for the distribution to and from airports and seaports, making it an essential component of the logistics chain. Sea shipping is indispensable for international trade, offering the ability to move large volumes at a lower cost. It stands as a cornerstone for global commerce, capable of transporting substantial volumes at decreased costs.
Drug Supply Stage: Utilization of in-house and outsourced management for inventory control as per their need in large and SMEs
In-house management grants companies direct control over their supply chains, promoting consistent adherence to high quality and regulatory standards and nimbly responding to changes in market needs. Firms opt for in-house operations, capitalizing on greater control over their supply chains, ensuring that stringent regulatory and quality standards are uniformly met, and facilitating swift adaptation to customer demands. On the other hand, outsourcing to specialized logistics providers can offer cost savings and access to specialized infrastructure, expansive networks, and cutting-edge technology, which can streamline the supply chain and potentially expedite the delivery of critical drugs to the marketplace. The choice between in-house and outsourcing logistics often depends on a company's size, the availability of resources, and the complexity of its drug portfolio, each pathway presenting its own set of strategic advantages.
Regional Insights
In the Americas, the United States and Canada are significant hubs in pharmaceutical logistics due to their large consumer market, sophisticated healthcare infrastructure, and a strong presence of global pharmaceutical corporations. The increasing demand for personalized medicine and a high chronic disease prevalence rate drive the demand for pharmaceutical logistics solutions in this region. Additionally, emerging markets in Latin America present a varied pharmaceutical logistics landscape, affected by disparate regulatory systems and the need for infrastructure improvements. Similarly, the European Union's pharmaceutical logistics sector is governed by tight regulations, especially concerning drug safety and traceability. Integrated logistics solutions are in demand in this region, bolstered by the high penetration of digital technologies to manage cross-border pharmaceutical flows. On the other hand, The logistics market in the Middle East is experiencing growth through strategic geographic positioning and investments in infrastructure such as air and sea ports. There's a rising demand for high-quality chronic care medications and an increase in private healthcare facilities, requiring prompt and advanced logistics solutions. Moreover, the Asia-Pacific region is experiencing significant growth in the pharmaceutical logistics market, driven by the expanding healthcare sector, advancements in pharmaceutical manufacturing, and the increasing demand for efficient distribution of medical products. Factors such as a swelling patient pool, government initiatives to improve healthcare infrastructure, and a surge in the pharmaceutical industry's focus on emerging markets are key contributors to this growth.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Pharmaceutical Logistics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Pharmaceutical Logistics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Pharmaceutical Logistics Market, highlighting leading vendors and their innovative profiles. These include A.P. Moller - Maersk A/S, Air Canada, AIT Worldwide Logistics, Inc., Almac Group, AmerisourceBergen Corporation, AWL India Private Limited, Bilcare Limited, C.H. Robinson Worldwide, Inc., Catalent, Inc., CEVA Logistics, Clinigen Group PLC, Crown LSP Group, DHL International GmbH by Deutsche Post AG, DSV A/S, FedEx Corporation, ICON PLC, Infosys Limited, Kerry Logistics Network Limited, Kuehne + Nagel International AG, Lineage, Inc., Lonza Group Ltd., Movianto Group, NextPharma Logistics GmbH, Nippon Express Co., Ltd., Parexel International Corporation, SEKO Logistics, SF Express Co., Ltd., Thermo Fisher Scientific, Inc., United Parcel Service of America, Inc., and YUSEN LOGISTICS CO., LTD..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Pharmaceutical Logistics Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Pharmaceutical Logistics Market?
3. What are the technology trends and regulatory frameworks in the Pharmaceutical Logistics Market?
4. What is the market share of the leading vendors in the Pharmaceutical Logistics Market?
5. Which modes and strategic moves are suitable for entering the Pharmaceutical Logistics Market?